Pharmaceuticals sector
99 companies · ₹25.0 L cr · 51 with AI deep dives
5y revenue CAGR
median 8.85%(p25 4.68% · p75 12.45%)
5y avg ROCE
median 14.57%(p25 10.39% · p75 20.5%)
Debt / equity
median 0.26x(p25 0.07x · p75 0.44x)
AI sector brief
from the bucket's latest earnings calls · as of 2026-06-30headwindMiddle East geopolitical disruption driving widespread RM, freight and supply-chain stress12 managements
More companies flagged this than any other single theme. Managements described force majeure declarations from raw material suppliers, freight rerouting surcharges (ocean +15%…
- LUPIN (Q4FY26): “Ocean freight is about 15% higher, air freight is about 60% higher. There are of course…”
tailwind8 managements🔒headwind5 managements🔒mixed6 managements🔒tailwind5 managements🔒tailwind6 managements🔒headwind4 managements🔒tailwind4 managements🔒
7 more themes from this quarter's earnings calls are locked. A free account opens the full brief: every theme with verbatim management quotes, the demand picture, companies running against the tide, and the regulatory & disruption watch. Sign up free →
| Company | Mcap | AI verdict | Signals | Stated KPIs (latest call) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹4.7 L cr | Unlock | earnings quality strongnet cash | |
| Divis Laboratories Ltd | ₹2.0 L cr | Unlock | capex coming onlinepharma capex digesting | |
| Torrent Pharmaceuticals Ltd | ₹1.7 L cr | Unlock | latent operating leverageearnings quality stronglevering up | |
| Cipla Ltd | ₹1.2 L cr | Unlock | earnings quality strongnet cash | |
| Zydus Lifesciences Ltd | ₹1.1 L cr | Unlock | ||
| Lupin Ltd | ₹1.1 L cr | Unlock | earnings quality strong | |
| Mankind Pharma Ltd | ₹1.1 L cr | Unlock | latent operating leverageearnings quality strong | |
| Laurus Labs Ltd | ₹94,976 cr | Unlock | earnings quality strong | |
| Dr Reddys Laboratories Ltd | ₹94,790 cr | Unlock | latent operating leverageearnings quality strong | |
| Aurobindo Pharma Ltd | ₹89,707 cr | Unlock | capex coming onlineearnings quality strongpharma capex digesting | |
| Biocon Ltd | ₹70,386 cr | Unlock | earnings quality strongdeleveraging | |
| Alkem Laboratories Ltd | ₹67,387 cr | Unlock | ||
| Glenmark Pharmaceuticals Ltd | ₹61,808 cr | Unlock | earnings quality strong | |
| Ipca Laboratories Ltd | ₹45,413 cr | Unlock | earnings quality strongnet cash | |
| Glaxosmithkline Pharmaceuticals Ltd | ₹45,062 cr | Unlock | roce compounderearnings quality strong | |
| Ajanta Pharma Ltd | ₹41,675 cr | Unlock | roce compoundernet cash | |
| Gland Pharma Ltd | ₹40,168 cr | Unlock | latent operating leveragenet cash | |
| J B Chemicals & Pharmaceuticals Ltd | ₹38,731 cr | Unlock | roce compounderearnings quality strong | |
| Emcure Pharmaceuticals Ltd | ₹35,858 cr | Unlock | roce compounderearnings quality strong | |
| Wockhardt Ltd | ₹30,660 cr | Unlock | capex coming onlinedeleveragingpharma capex digesting | |
| Sai Life Sciences Ltd | ₹27,604 cr | Unlock | earnings quality strongnet cash | |
| Piramal Pharma Ltd | ₹25,748 cr | Unlock | deleveraging | |
| Neuland Laboratories Ltd | ₹24,352 cr | Unlock | earnings quality strong | |
| Pfizer Ltd | ₹21,595 cr | Unlock | roce compoundernet cash | |
| Granules India Ltd | ₹21,141 cr | Unlock | earnings quality strong | |
| Astrazeneca Pharma India Ltd | ₹20,142 cr | Unlock | earnings quality weak | |
| OneSource Specialty Pharma Ltd | ₹19,804 cr | Unlock | ||
| Caplin Point Laboratories Ltd | ₹19,623 cr | Unlock | capex coming onlineroce compoundernet cashpharma capex digesting | |
| ERIS Lifesciences Ltd | ₹19,294 cr | Unlock | earnings quality strong | |
| Natco Pharma Ltd | ₹16,639 cr | Unlock | net cash | |
| Cohance Lifesciences Ltd | ₹16,297 cr | Unlock | latent operating leverageearnings quality strongnet cash | |
| Alembic Pharmaceuticals Ltd | ₹16,099 cr | Unlock | earnings quality strongpharma capex digesting | |
| Jubilant Pharmova Ltd | ₹15,371 cr | Unlock | capex coming onlineearnings quality strongdeleveragingpharma capex digesting | |
| Alivus Life Sciences Ltd | ₹13,534 cr | Unlock | capex coming onlineroce compoundercapex ahead of revenuepharma capex digesting | |
| Concord Biotech Ltd | ₹13,087 cr | Unlock | ||
| Shilpa Medicare Ltd | ₹11,839 cr | Unlock | capex coming onlineearnings quality strongpharma capex digesting | |
| Marksans Pharma Ltd | ₹11,646 cr | Unlock | net cash | |
| Procter & Gamble Health Ltd | ₹11,088 cr | Unlock | roce compounder | |
| Viyash Scientific Ltd | ₹11,081 cr | Unlock | latent operating leverageearnings quality strong | |
| Sanofi Consumer Healthcare India Ltd | ₹10,842 cr | Unlock | roce compounderearnings quality strong | |
| Akums Drugs & Pharmaceuticals Ltd | ₹10,416 cr | Unlock | earnings quality strongnet cash | |
| Blue Jet Healthcare Ltd | ₹9,931 cr | Unlock | capex coming onlineroce compounderpharma capex digesting | |
| Strides Pharma Science Ltd | ₹9,545 cr | Unlock | deleveragingpharma capex digesting | |
| Sanofi India Ltd | ₹7,761 cr | Unlock | roce compounder | |
| Sun Pharma Advanced Research Company Ltd | ₹6,812 cr | Unlock | capex coming onlinepharma capex digesting | |
| Supriya Lifescience Ltd | ₹6,686 cr | Unlock | latent operating leverage | |
| FDC Ltd | ₹6,679 cr | Unlock | ||
| Aarti Pharmalabs Ltd | ₹6,130 cr | Unlock | latent operating leveragecapex coming onlineearnings quality strongcapex ahead of revenue | |
| Senores Pharmaceuticals Ltd | ₹6,108 cr | Unlock | capex coming onlineearnings quality weakpharma capex digesting | |
| Innova Captab Ltd | ₹5,464 cr | Unlock | ||
| Orchid Pharma Ltd | ₹5,001 cr | Unlock | capex coming onlineearnings quality strongcapex ahead of revenuepharma capex digesting | |
| Bliss GVS Pharma Ltd | ₹4,814 cr | Unlock | earnings quality strongnet cash | |
| RPG Life Sciences Ltd | ₹4,790 cr | Unlock | roce compounderearnings quality weaknet cash | |
| IOL Chemicals & Pharmaceuticals Ltd | ₹4,315 cr | Unlock | earnings quality strongnet cash | |
| Gufic BioSciences Ltd | ₹3,901 cr | Unlock | deleveraging | |
| Unichem Laboratories Ltd | ₹3,775 cr | Unlock | ||
| Aarti Drugs Ltd | ₹3,701 cr | Unlock | latent operating leverageearnings quality strongdeleveraging | |
| SMS Pharmaceuticals Ltd | ₹3,568 cr | Unlock | deleveragingpharma capex digesting | |
| Morepen Laboratories Ltd | ₹3,030 cr | Unlock | latent operating leverage | |
| Dishman Carbogen Amcis Ltd | ₹2,853 cr | Unlock | ||
| Hikal Ltd | ₹2,679 cr | Unlock | latent operating leverageearnings quality strongdeleveragingcapital destroyer | |
| Panacea Biotec Ltd | ₹2,539 cr | Unlock | capex coming onlinenet cashpharma capex digesting | |
| Solara Active Pharma Sciences Ltd | ₹2,448 cr | Unlock | deleveraging | |
| Hester Biosciences Ltd | ₹2,125 cr | Unlock | earnings quality strongdeleveraging | |
| Indoco Remedies Ltd | ₹2,105 cr | Unlock | latent operating leverageearnings quality stronglevering up | |
| Ind-Swift Laboratories Ltd | ₹2,066 cr | Unlock | net cash | |
| Venus Remedies Ltd | ₹2,046 cr | Unlock | earnings quality strongpharma capex digesting | |
| NGL Fine Chem Ltd | ₹1,986 cr | Unlock | capex coming onlinepharma capex digesting | |
| Windlas Biotech Ltd | ₹1,750 cr | Unlock | capex coming onlineearnings quality strongnet cashpharma capex digesting | |
| Amrutanjan Health Care Ltd | ₹1,477 cr | Unlock | capex coming onlinepharma capex digesting | |
| Jagsonpal Pharmaceuticals Ltd | ₹1,473 cr | Unlock | latent operating leverageearnings quality strong | |
| Syncom Formulations (India) Ltd | ₹1,230 cr | Unlock | net cash | |
| Lincoln Pharmaceuticals Ltd | ₹1,152 cr | Unlock | net cash | |
| Wanbury Ltd | ₹1,089 cr | Unlock | roce compounderdeleveraging | |
| Bajaj Healthcare Ltd | ₹1,071 cr | Unlock | earnings quality strongdeleveraging | |
| Themis Medicare Ltd | ₹976 cr | Unlock | earnings quality weakcyclical peak base | |
| Sigachi Industries Ltd | ₹971 cr | Unlock | latent operating leverage | |
| Kopran Ltd | ₹960 cr | Unlock | latent operating leverage | |
| Kilitch Drugs (India) Ltd | ₹643 cr | Unlock | capex coming onlinepharma capex digesting | |
| Zim Laboratories Ltd | ₹617 cr | Unlock | latent operating leveragecapex coming onlineearnings quality strongcapex ahead of revenue | |
| Bafna Pharmaceuticals Ltd | ₹600 cr | Unlock | latent operating leverageearnings quality strong | |
| Haleos Labs Ltd | ₹460 cr | Unlock | earnings quality strongdeleveraging | |
| Transchem Ltd | ₹419 cr | Unlock | earnings quality strong | |
| Albert David Ltd | ₹395 cr | Unlock | net cashpharma capex digesting | |
| Medico Remedies Ltd | ₹344 cr | Unlock | roce compounder | |
| Medicamen Biotech Ltd | ₹333 cr | Unlock | ||
| Valiant Laboratories Ltd | ₹329 cr | Unlock | ||
| Lyka Labs Ltd | ₹225 cr | Unlock | earnings quality strongdeleveraging | |
| Aarey Drugs & Pharmaceuticals Ltd | ₹220 cr | Unlock | earnings quality weak | |
| Nectar Lifescience Ltd | ₹199 cr | Unlock | ||
| Brooks Laboratories Ltd | ₹185 cr | Unlock | net cash | |
| Bal Pharma Ltd | ₹139 cr | Unlock | earnings quality stronglevering up | |
| Alpa Laboratories Ltd | ₹138 cr | Unlock | latent operating leverageearnings quality weaknet cash | |
| Krebs Biochemicals & Industries Ltd | ₹115 cr | Unlock | latent operating leverage | |
| Vineet Laboratories Ltd | ₹75 cr | Unlock | latent operating leveragelevering up | |
| Biofil Chemicals & Pharmaceuticals Ltd | ₹53 cr | Unlock | ||
| Mangalam Drugs & Organics Ltd | ₹43 cr | Unlock | levering up | |
| Lasa Supergenerics Ltd | ₹35 cr | Unlock | capex coming onlinecapex ahead of revenuecapital destroyerpharma capex digesting | |
| Ortin Global Ltd | ₹12 cr | Unlock | capital destroyer |